Navigation Links
John Theurer Cancer Center and Leukemia & Lymphoma Society Highlight Upcoming Trends in Hematological Malignancies
Date:9/21/2009

HACKENSACK, N.J., Sept. 21 /PRNewswire/ -- The John Theurer Cancer Center at Hackensack University Medical Center, the nation's fourth largest cancer center, and the Leukemia & Lymphoma Society have joined forces to host the Hematological Malignancies Conference on Saturday, September 26, 2009 in Hackensack, NJ. The conference is free and attendees can receive continuing medical education (CME) credits.

Hematological malignancies are the types of cancer that affect blood, bone marrow, and lymph nodes.

Oncology experts from leading cancer organizations from around the country, including the John Theurer Cancer Center, MD Anderson Cancer Center, the Mayo Clinic, Dana Farber Cancer Institute and the National Cancer Institute, will discuss trends in patient care, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies. Key topics include chronic lymphocytic leukemia, the role of molecular biomarkers in diffuse large b-cell lymphoma, follicular lymphoma, management of multiple myeloma and immunomodulation and hematopoietic stem cell transplant.

Featured Speakers:

  • Andre Goy, M.D. - Deputy Director, John Theurer Cancer Center, Chief, Division of Lymphoma; Director, Cancer Research
  • Susan O'Brien, M.D. - MD Anderson Cancer Center; Professor, Department of Leukemia, Division of Cancer Medicine
  • Wyndham Wilson, M.D., Ph.D. - National Cancer Institute, Chief, Lymphoma Therapeutics, Metabolic Branch, Center for Cancer Research
  • Carol Portlock, M.D. - Memorial Sloane-Kettering Cancer Center, Professor of Medicine, Attending Physician of Lymphoma
  • Rafael Fonseca, M.D. - Mayo Clinic, Professor of Medicine, Deputy Director of Mayo Clinic Cancer Center
  • Robert J. Soiffer, M.D. - Dana Farber Cancer Institute, Harvard Medical Professor of Medicine, Harvard Medical School, Chief Division of Blood Centers

This conference is open to the public, but directed primarily for medical oncologists and hematologists, as well as other healthcare professionals in the oncology field who are interested in the treatment of cancer. The conference will be held from 8 am to 2:30 pm in the Hekemian Conference Center Auditorium located at Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey. If you're interested in attending please contact David Marisol at 201-996-2515 or marisoldavid@humed.com.

John Theurer Cancer Center at Hackensack University Medical Center

The John Theurer Cancer Center at Hackensack University Medical Center is New Jersey's largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancer. The 15 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. Housed within a 775-bed, not-for-profit teaching, tertiary care, and research hospital, the John Theurer Cancer Center provides state-of-the-art technological advances, compassionate care, research innovations, medical expertise, and a full range of after care services that distinguish the John Theurer Cancer Center from other facilities.


'/>"/>
SOURCE The John Theurer Cancer Center at Hackensack University Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. News from Medialink and P&G: Procter & Gamble Partners with National Breast Cancer Foundation, Inc. to GIVE HOPE to Millions of Women Across the Country
2. Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer
3. Surgeon Battling Own Cancer Developed New Treatment
4. New Chemo Regimen May Benefit Ovarian Cancer Patients
5. New Drug May Offer Hope to Some With Lung Cancer
6. Hormone Therapy May Make Lung Cancer More Likely
7. Mens Health Network, The Washington Redskins and GlaxoSmithKline Team Up for Septembers Prostate Cancer Awareness Month
8. Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments
9. Henry Ford Hospital Offers Free Prostate Cancer Screenings
10. Scientists May Know How Lung Cancer Spreads
11. The Lustgarten Foundation Expresses Condolences as Pancreatic Cancer Claims Life of Myles Brand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... The Waismann Method® is ... individuals who have recently fallen victim to America’s opioid epidemic. Now, opiate dependent individuals ... where they are free from the shame, stigma, and harmful labeling believed ...
(Date:2/22/2017)... ... 2017 , ... The National Academy of Certified Care Managers ... 2017 testing period. NACCM, a nonprofit organization, has provided the premier certification for ... periodically re-calibrated to ensure that newly certified professionals are prepared to work effectively ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes ... emergency room, fewer hospital admissions, and better blood pressure and glycemic control, a ... The study can be found here . , The study comes as ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, over ... not filling a prescription because they could not afford to pay for it. ... were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and nursing ...
(Date:2/22/2017)... Los Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... with the recent addition of esteemed ophthalmologist, Dr. Steven H. Rauchman, practicing at ... are common in auto accidents, product liability, premise liability and other personal injury cases. ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... February 22, 2017 According to a new ... Trocar, SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), & ... 2021", published by MarketsandMarkets, the global market is expected to reach ... at a CAGR of 7.1% during the forecast period. ... ...
(Date:2/22/2017)... and PUNE, India , February 22, 2017 ... Market Research, titled, "Automated Radio Synthesis Modules Market: Global Opportunity ... radiosynthesis modules market was worth $20 million in 2015 and ... CAGR of 6.6% from 2016 to 2022. North ... of both market revenues and unit volumes, whereas ...
(Date:2/22/2017)... Feb. 22, 2017   Protein Sciences Corporation , ... Flublok® Influenza Vaccine , announced today that they donated ... Vaccine Introduction (PIVI) and the Mongolian Ministry of Health ... the flu.  The doses of Flublok have been distributed ... for health care workers, pregnant women, and ...
Breaking Medicine Technology: